Parasitic infections in solid-organ transplant recipients

Current Opinion in Organ Transplantation

Volumn 16, Issue 6, 2011, Pages 565-575

  Muñoz, Patricia ^a   Valerio, Maricela ^a   Eworo, Alia ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chagas' disease; Cryptosporidium; Leishmania; malaria; Microsporidium; parasitic infections; solid organ transplant; Strongyloides; toxoplasmosis; transplantation

Indexed keywords

ALBENDAZOLE; ALLOPURINOL; AMPHOTERICIN B LIPID COMPLEX; ARTEETHER; ARTEMISINIC ACID; ARTESUNATE; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; DOXYCYCLINE; DROTRECOGIN; FLUCONAZOLE; FOLINIC ACID; FUMAGILLIN; ITRACONAZOLE; IVERMECTIN; KETOCONAZOLE; MEFLOQUINE; METRONIDAZOLE; MILTEFOSINE; NITAZOXANIDE; PAROMOMYCIN; PYRIMETHAMINE; QUININE; SULFADIAZINE; TETRACYCLINE; TIABENDAZOLE; UNINDEXED DRUG;

ACANTHAMOEBA INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CHAGAS DISEASE; CHORIORETINITIS; CRYPTOSPORIDIOSIS; DIFFERENTIAL DIAGNOSIS; GRAFT RECIPIENT; HUMAN; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LIVER TOXICITY; MALARIA; MEDICAL TOURISM; MICROSPORIDIOSIS; PARASITOSIS; PLASMODIUM FALCIPARUM; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; REVIEW; SINGLE DRUG DOSE; SKIN LEISHMANIASIS; STRONGYLOIDIASIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPARASITIC AGENTS; ENDEMIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PARASITIC DISEASES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 81355160205     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834cdbb0     Document Type: Review

References (163)

1. Martin-Davila P, Fortun J, Lopez-Velez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 2008; 21:60-96. (Pubitemid 351160010)
2. Kotton CN. Transplant tourism and donor-derived parasitic infections. Transplant Proc 2011; 43:2448-2449.
3. Jacobs F, Depierreux M, Goldman M, et al. Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis. Rev Infect Dis 1991; 13:637-641.
4. Feron D, Goldman M, Jacobs F, et al. Bone marrow aspiration as a diagnostic tool for acute toxoplasmosis in a kidney transplant recipient. Transplantation 1990; 50:1054-1055.
5. Rostaing L, Baron E, Fillola O, et al. Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration. Transplant Proc 1995; 27:1733-1734.
6. Campbell AL, Goldberg CL, Magid MS, et al. First case of toxoplasmosis following small bowel transplantation and systematic review of tissueinvasive toxoplasmosis following noncardiac solid organ transplantation. Transplantation 2006; 81:408-417. (Pubitemid 43255727)
7. Vaessen N, Verweij JJ, Spijkerman IJ, et al. Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCR. Neth J Med 2007; 65:222-223. (Pubitemid 47007919)
8. Caner A, Doskaya M, Karasu Z, et al. Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in western Turkey. Liver Transpl 2008; 14:1526-1532.
9. Patrat-Delon S, Gangneux JP, Lavoue S, et al. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J Clin Microbiol 2011; 48:2541-2545.
10. Jokipii L, Salmela K, Saha H, et al. Leishmaniasis diagnosed from bronchoalveolar lavage. Scand J Infect Dis 1992; 24:677-681.
11. Basset D, Faraut F, Marty P, et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 2005; 7:1370-1375. (Pubitemid 41572314)
12. Berenguer J, Gomez-Campdera F, Padilla B, et al. Visceral leishmaniasis (kala-azar) in transplant recipients: case report and review. Transplantation 1998; 65:1401-1404. (Pubitemid 28283108)
13. White NJ. The treatment of malaria. N Engl J Med 1996; 335:800-806. (Pubitemid 26296541)
14. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66-78. (Pubitemid 34052582)
15. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennetts principles and practice of infectious diseases, vol. 2. 6th ed. Philadelphia, Pennsylvania: Elsevier Churchill Livingstone; 2005.
16. Maltha J, Gillet P, Cnops L, et al. Malaria rapid diagnostic tests: Plasmodium falciparum infections with high parasite densities may generate false positive Plasmodium vivax pLDH lines. Malar J 2010; 9:198-204.
17. Abba K, Deeks JJ, Olliaro P, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev 2011:CD008122.
18. Boonma P, Christensen PR, Suwanarusk R, et al. Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum. Malar J 2007; 6:124.
19. Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK. Multiplexedreal-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol 2009; 47:975-980.
20. Mali S, Tan KR, Arguin PM. Malaria surveillance: United States, 2009. MMWR Surveill Summ 2011; 60:1-15.
21. Didier ES, Weiss LM. Microsporidiosis: current status. Curr Opin Infect Dis 2006; 19:485-492. (Pubitemid 44338109)
22. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 2006; 42:115-125. (Pubitemid 41832090)
23. Conteas CN, Sowerby T, Berlin GW, et al. Fluorescence techniques for diagnosing intestinal microsporidiosis in stool, enteric fluid, and biopsy specimens from acquired immunodeficiency syndrome patients with chronic diarrhea. Arch Pathol Lab Med 1996; 120:847-853. (Pubitemid 26326107)
24. Fedorko DP, Hijazi YM. Application of molecular techniques to the diagnosis of microsporidial infection. Emerg Infect Dis 1996; 2:183-191. (Pubitemid 126444985)
25. Van Gool T, Snijders F, Reiss P, et al. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol 1993; 46:694-699. (Pubitemid 23242416)
26. Didier ES. Immunology of microsporidiosis. Contrib Microbiol 2000; 6:193-208.
27. Fedorko DP, Nelson NA, Didier ES, et al. Speciation of human microsporidia by polymerase chain reaction single-strand conformation polymorphism. Am J Trop Med Hyg 2001; 65:397-401. (Pubitemid 33022032)
28. Hoepelman AI. Current therapeutic approaches to cryptosporidiosis in immunocompromised patients. J Antimicrob Chemother 1996; 37:871-880. (Pubitemid 26158775)
29. Sebastian E, Martin J, McDonald GB, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant 2011; 46:612-614.
30. Guerrant RL. Cryptosporidiosis: an emerging, highly infectious threat. Emerg Infect Dis 1997; 3:51-57. (Pubitemid 127433639)
31. Beal CB, Viens P, Grant RG, Hughes JM. A new technique for sampling duodenal contents: demonstration of upper small-bowel pathogens. Am J Trop Med Hyg 1970; 19:349-352.
32. Rosenblatt JE. Clinical importance of adequately performed stool ova and parasite examinations. Clin Infect Dis 2006; 42:979-980.
33. Martin-Rabadan P, Munoz P, Palomo J, Bouza E. Strongyloidiasis: the Harada-Mori test revisited. Clin Microbiol Infect 1999; 5:374-376. (Pubitemid 29312616)
34. Abdalla J, Saad M, Myers JW, Moorman JP. An elderly man with immunosuppression, shortness of breath, and eosinophilia. Clin Infect Dis 2005; 40:1464; 1535-1466.
35. Smith B, Verghese A, Guiterrez C, et al. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am J Med 1985; 79:663-666. (Pubitemid 16191223)
36. Harris RA Jr, Musher DM, Fainstein V, et al. Disseminated strongyloidiasis. Diagnosis made by sputum examination. JAMA 1980; 244:65-66. (Pubitemid 10071582)
37. Sreenivas DV, Kumar A, Kumar YR, et al. Intestinal strongyloidiasis: a rare opportunistic infection. Indian J Gastroenterol 1997; 16:105-106. (Pubitemid 27318002)
38. Overstreet K, Chen J, Rodriguez JW, Wiener G. Endoscopic and histopathologic findings of Strongyloides stercoralis infection in a patient with AIDS. Gastrointest Endosc 2003; 58:928-931. (Pubitemid 37521670)
39. El Masry HZ, ODonnell J. Fatal strongyloides hyperinfection in heart transplantation. J Heart Lung Transplant 2005; 24:1980-1983.
40. Angelis M, Cooper JT, Freeman RB. Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transpl 2003; 9:451-462. (Pubitemid 36621712)
41. Ferraz AS, Figueiredo JF. Transmission of Chagas disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo 1993; 35:461-463.
42. Salomone OA, Basquiera AL, Sembaj A, et al. Trypanosoma cruzi in persons without serologic evidence of disease, Argentina. Emerg Infect Dis 2003; 9:1558-1562. (Pubitemid 37505451)
43. Sluiters JF, Balk AH, Essed CE, et al. Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients. J Clin Microbiol 1989; 27:529-535. (Pubitemid 19072366)
44. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-1976. (Pubitemid 38759657)
45. Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996; 15:389-393. (Pubitemid 26181638)
46. Giordano LF, Lasmar EP, Tavora ER, Lasmar MF. Toxoplasmosis transmitted via kidney allograft: case report and review. Transplant Proc 2002; 34:498-499. (Pubitemid 34497220)
47. Drugs for parasitic infections. Med Lett Drugs Ther 2004; 46:1-2.
48. Sundar S, Rai M, Chakravarty J, et al. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 2008; 47:1000-1006.
49. Llorente S, Gimeno L, Navarro MJ, et al. Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation 2000; 70:800-801.
50. Lopez-Velez R, Videla S, Marquez M, et al. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 2004; 53:540-543. (Pubitemid 38380259)
51. Fernandez-Guerrero ML, Robles P, Rivas P, et al. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 2004; 90:11-16. (Pubitemid 38117052)
52. Horber FF, Lerut JP, Reichen J, et al. Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly. Transpl Int 1993; 6:55-57. (Pubitemid 23015186)
53. Hernandez-Perez J, Yebra-Bango M, Jimenez-Martinez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999; 29:918-921. (Pubitemid 30256389)
54. Sinclair D, Zani B, Donegan S, et al. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev 2009:CD007483.
55. Einollahi B. Plasmodium falciparum infection transmitted by living kidney donation: a case report from Iran. Ann Transplant 2008; 13:75-78.
56. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005; 5:8-14. (Pubitemid 40095122)
57. Fischer L, Sterneck M, Claus M, et al. Transmission of malaria tertiana by multiorgan donation. Clin Transplant 1999; 13:491-495. (Pubitemid 30011426)
58. Huston CD, Petri WA Jr. Emerging and reemerging intestinal protozoa. Curr Opin Gastroenterol 2001; 17:17-23. (Pubitemid 32098885)
59. Sun T, Kaplan MH, Teichberg S, et al. Intestinal microsporidiosis. Report of five cases. Ann Clin Lab Sci 1994; 24:521-532. (Pubitemid 24332451)
60. Champion L, Durrbach A, Lang P, et al. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Am J Transplant 2010; 10:1925-1930.
61. Abubakar I, Aliyu SH, Arumugam C, et al. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 2007; 63:387-393. (Pubitemid 46426641)
62. Tran MQ, Gohh RY, Morrissey PE, et al. Cryptosporidium infection in renal transplant patients. Clin Nephrol 2005; 63:305-309. (Pubitemid 40542392)
63. Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, et al. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother 2004; 5:2615-2619. (Pubitemid 39646523)
64. Zaha O, Hirata T, Kinjo F, et al. Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J Infect Chemother 2002; 8:94-98. (Pubitemid 34456587)
65. Fardet L, Genereau T, Cabane J, Kettaneh A. Severe strongyloidiasis in corticosteroid-treated patients. Clin Microbiol Infect 2006; 12:945-947. (Pubitemid 44322565)
66. Weiser JA, Scully BE, Bulman WA, et al. Periumbilical parasitic thumbprint purpura: Strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. Transpl Infect Dis 2011; 13:58-62.
67. Tarr PE, Miele PS, Peregoy KS, et al. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003; 68:453-455. (Pubitemid 38230646)
68. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005; 41:e5-e8.
69. Pacanowski J, Santos MD, Roux A, et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005; 73:122-124. (Pubitemid 41278760)
70. Huston JM, Eachempati SR, Rodney JR, et al. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl Infect Dis 2009; 11:277-280.
71. DeVault GA Jr, King JW, Rohr MS, et al. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12:653-671. (Pubitemid 20223416)
72. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:2171-2181. (Pubitemid 350106656)
73. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006; 144:724-734. (Pubitemid 46780632)
74. Hebraud B, Kamar N, Borde JS, et al. Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure. NDT Plus 2008; 1:429-432.
75. Munoz P, Arencibia J, Rodriguez C, et al. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis 2003; 36:932-933; author reply 933. (Pubitemid 36403529)
76. Murri R, Ammassari A, Pezzotti P, et al. Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. J Acquir Immune Defic Syndr 2001; 27:49-55. (Pubitemid 32587242)
77. Girard PM, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. N Engl J Med 1993; 328:1514-1520. (Pubitemid 23147780)
78. Gourishankar S, Doucette K, Fenton J, et al. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 2008; 85:980-985. (Pubitemid 351543161)
79. Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44:857-866. (Pubitemid 46365315)
80. Morales P, Torres JJ, Salavert M, et al. Visceral leishmaniasis in lung transplantation. Transplant Proc 2003; 35:2001-2003. (Pubitemid 37093792)
81. Anteyi EA, Liman HM, Gbaji A. Malaria prophylaxis in post renal transplant recipients in the tropics: is it necessary? Cent Afr J Med 2003; 49: 63-66.
82. Boggild AK, Sano M, Humar A, et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004; 11:37-43. (Pubitemid 38198774)
83. Freedman DO. Clinical practice. Malaria prevention in short-term travelers. N Engl J Med 2008; 359:603-612.
84. Vekemans J, Marsh K, Greenwood B, et al. Assessment of severe malaria in a multicenter, phase III, RTS,S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J 2011; 10:221-261.
85. Jelinek T, Lotze M, Eichenlaub S, et al. Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travellers. Gut 1997; 41:801-804. (Pubitemid 28023183)
86. Hamilton KW, Abt PL, Rosenbach MA, et al. Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation 2011; 91:1019-1024.
87. Said T, Nampoory MR, Nair MP, et al. Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait. Transplant Proc 2007; 39:1014-1015. (Pubitemid 46764886)
88. Briasoulis A, Psevdos G. Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient. South Med J 2011; 104:72-73.
89. Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14:1089-1101.
90. Nasser QJ, Power RE, Eng MP, et al. Toxoplasmosis after a simultaneous pancreas and kidney transplantation. Transplant Proc 2004; 36:2843-2844. (Pubitemid 40036852)
91. Rogers NM, Peh CA, Faull R, et al. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transpl Infect Dis 2008; 10:71-74. (Pubitemid 351171317)
92. Wulf MW, van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005; 43:3544-3547. (Pubitemid 40981390)
93. Singh N, Husain S. Infections of the central nervous system in transplant recipients. Transpl Infect Dis 2000; 2:101-111.
94. Martinez-Giron R, Esteban JG, Ribas A, Doganci L. Protozoa in respiratory pathology: a review. Eur Respir J 2008; 32:1354-1370.
95. Conrath J, Mouly-Bandini A, Collart F, Ridings B. Toxoplasma gondii retinochoroiditis after cardiac transplantation. Graefes Arch Clin Exp Ophthalmol 2003; 241:334-338. (Pubitemid 36748566)
96. Segall L, Moal MC, Doucet L, et al. Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transpl Int 2006; 19:78-80.
97. Mayes JT, OConnor BJ, Avery R, et al. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995; 21:511-515.
98. Choi CM, Lerner EA. Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc 2001; 6:175-182. (Pubitemid 33758571)
99. Barsoum RS. Parasitic infections in organ transplantation. Exp Clin Transplant 2004; 2:258-267.
100. Golino A, Duncan JM, Zeluff B, et al. Leishmaniasis in a heart transplant patient. J Heart Lung Transplant 1992; 11:820-823.
101. Clemente WT, Faria LC, Romanelli RM, et al. Visceral leishmaniasis in liver transplant recipients from an endemic area. Transplantation 2011; 91:806-808.
102. Frapier JM, Abraham B, Dereure J, Albat B. Fatal visceral leishmaniasis in a heart transplant recipient. J Heart Lung Transplant 2001; 20:912-913. (Pubitemid 32743140)
103. Tavora ER, Lasmar EP, Orefice J, et al. Unusual manifestations of leishmaniasis in renal transplant. Transplant Proc 2002; 34:502-503. (Pubitemid 34497222)
104. Gontijo CM, Pacheco RS, Orefice F, et al. Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient. Mem Inst Oswaldo Cruz 2002; 97:751-753. (Pubitemid 135746097)
105. Fernandes IM, Baptista MA, Barbon TR, et al. Cutaneous leishmaniasis in kidney transplant recipient. Transplant Proc 2002; 34:504-505. (Pubitemid 34497223)
106. Naseem S, Ahluwalia J, Sharma A. Malaria with leukopenia in a renal transplant patient. Transplantation 2011; 91:e78-e79.
107. Gueco I, Saniel M, Mendoza M, et al. Tropical infections after renal transplantation. Transplant Proc 1989; 21:2105-2107. (Pubitemid 19131151)
108. Franco-Paredes C, Jacob JT, Hidron A, et al. Transplantation and tropical infectious diseases. Int J Infect Dis 2010; 14:e189-e196.
109. Sabbatani S, Fiorino S, Manfredi R. The emerging of the fifth malaria parasite (Plasmodium knowlesi): a public health concern? Braz J Infect Dis 2010; 14:299-309.
110. Turkmen A, Sever MS, Ecder T, et al. Posttransplant malaria. Transplantation 1996; 62:1521-1523. (Pubitemid 26404682)
111. Vijayan VK. Parasitic lung infections. Curr Opin Pulm Med 2009; 15:274-282.
112. Patankar TF, Karnad DR, Shetty PG, et al. Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology 2002; 224:811-816. (Pubitemid 34919818)
113. Cruz I, Mody V, Callender C, Hosten A. Malaria infection in transplant recipient. J Natl Med Assoc 1978; 70:105-107. (Pubitemid 9035113)
114. Seth AK, Puri P, Chandra A, et al. Mixed Plasmodium falciparum and Plasmodium vivax malaria in orthotopic liver transplant recipient. Transplantation 2009; 88:288.
115. Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol 2000; 11:2147-2154.
116. Babinet J, Gay F, Bustos D, et al. Transmission of Plasmodium falciparum by heart transplant. BMJ 1991; 303:1515-1516.
117. Chiche L, Lesage A, Duhamel C, et al. Posttransplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients. Transplantation 2003; 75:166-168.
118. WHO Expert Committee. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1991; 811:1-95.
119. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991; 31:547-557.
120. Kerndt PR, Waskin HA, Kirchhoff LV, et al. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991; 31:814-818.
121. Nowicki MJ, Chinchilla C, Corado L, et al. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Transplantation 2006; 81:477-479. (Pubitemid 43255738)
122. Riarte A, Luna C, Sabatiello R, et al. Chagas disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999; 29:561-567. (Pubitemid 29439954)
123. De Faria JB, Alves G. Transmission of Chagas disease through cadaveric renal transplantation. Transplantation 1993; 56:1583-1584. (Pubitemid 24018840)
124. Vazquez MC, Sabbatiello R, Schiavelli R, et al. Chagas disease and transplantation. Transplant Proc 1996; 28:3301-3303. (Pubitemid 26415491)
125. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48:1534-1540.
126. Campos SV, Strabelli TM, Amato Neto V, et al. Risk factors for Chagas disease reactivation after heart transplantation. J Heart Lung Transplant 2008; 27:597-602.
127. Centers of Disease Control and Prevention. Chagas disease after organ transplantation: Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:798-800.
128. Souza FF, Castro ESO, Marin Neto JA, et al. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc 2008; 40:875-878. (Pubitemid 351608636)
129. Steinberg JP, Galindo RL, Kraus ES, Ghanem KG. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clin Infect Dis 2002; 35:e43-e49.
130. Kramer MH, Lerner CJ, Visvesvara GS. Kidney and liver transplants from a donor infected with Naegleria fowleri. J Clin Microbiol 1997; 35:1032-1033. (Pubitemid 27146567)
131. Centers of Disease Control and Prevention. Notes from the field: transplanttransmitted Balamuthia mandrillaris: Arizona, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1182.
132. Centers of Disease Control and Prevention. Balamuthia mandrillaris transmitted through organ transplantation: Mississippi, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1165-1170.
133. Munoz P, Valerio M, Puga D, Bouza E. Parasitic infections in solid organ transplant recipients. Infect Dis Clin North Am 2010; 24:461-495.
134. Gumbo T, Hobbs RE, Carlyn C, et al. Microsporidia infection in transplant patients. Transplantation 1999; 67:482-484. (Pubitemid 29094024)
135. Didier ES. Microsporidiosis. Clin Infect Dis 1998; 27:1-7; quiz 8.
136. Latib MA, Pascoe MD, Duffield MS, Kahn D. Microsporidiosis in the graft of a renal transplant recipient. Transpl Int 2001; 14:274-277. (Pubitemid 32821771)
137. Gamboa-Dominguez A, De Anda J, Donis J, et al. Disseminated Encephalitozoon cuniculi infection in a Mexican kidney transplant recipient. Transplantation 2003; 75:1898-1900. (Pubitemid 36734649)
138. Mohindra AR, Lee MW, Visvesvara G, et al. Disseminated microsporidiosis in a renal transplant recipient. Transpl Infect Dis 2002; 4:102-107.
139. Carlson JR, Li L, Helton CL, et al. Disseminated microsporidiosis in a pancreas/kidney transplant recipient. Arch Pathol Lab Med 2004; 128: e41-e43.
140. Goetz M, Eichenlaub S, Pape GR, Hoffmann RM. Chronic diarrhea as a result of intestinal microsporidiosis in a liver transplant recipient. Transplantation 2001; 71:334-337. (Pubitemid 32126122)
141. Guerard A, Rabodonirina M, Cotte L, et al. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation 1999; 68:699-707.
142. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995; 21:57-62.
143. Acikgoz Y, Ozkaya O, Bek K, et al. Cryptosporidiosis: a rare and severe infection in a pediatric renal transplant recipient. Pediatr Transplant 2011. [Epub available online: 15-Feb-2011]
144. Rodriguez Ferrero ML, Munoz P, Valerio M, et al. Cryptosporidium parvum infection in a kidney transplant recipient. Nefrologia 2010; 30: 476-477.
145. Bandin F, Kwon T, Linas MD, et al. Cryptosporidiosis in paediatric renal transplantation. Pediatr Nephrol 2009.
146. Legrand F, Grenouillet F, Larosa F, et al. Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study. Bone Marrow Transplant 2011; 46:858-862.
147. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-154. (Pubitemid 34052587)
148. Campos M, Jouzdani E, Sempoux C, et al. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr 2000; 159:113-115. (Pubitemid 30120140)
149. Denkinger CM, Harigopal P, Ruiz P, Dowdy LM. Cryptosporidium parvumassociated sclerosing cholangitis in a liver transplant patient. Transpl Infect Dis 2008; 10:133-136. (Pubitemid 351393078)
150. Brugemann J, Kampinga GA, Riezebos-Brilman A, et al. Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise. J Heart Lung Transplant 2010; 29:1433-1437.
151. Ben-Youssef R, Baron P, Edson F, et al. Strongyloides stercoralis infection from pancreas allograft: case report. Transplantation 2005; 80:997-998. (Pubitemid 41552900)
152. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989; 11:755-767.
153. Nutman TB, Ottesen EA, Ieng S, et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis 1987; 155:309-313. (Pubitemid 17022874)
154. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-217. (Pubitemid 38120934)
155. Schaeffer MW, Buell JF, Gupta M, et al. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant 2004; 23:905-911. (Pubitemid 38953877)
156. Safdar A, Malathum K, Rodriguez SJ, et al. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004; 100:1531-1536.
157. Orlent H, Crawley C, Cwynarski K, et al. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 32:115-117. (Pubitemid 36850290)
158. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis 2009; 49:1411-1423.
159. Davidson RA. Issues in clinical parasitology: the management of hydatid cyst. Am J Gastroenterol 1984; 79:397-400. (Pubitemid 14147862)
160. Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev 1992; 5:345-355.
161. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-1047. (Pubitemid 32907108)
162. Palau LA, Pankey GA. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 1997; 57:413-415. (Pubitemid 27439110)
163. Nolan TJ, Schad GA. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 1996; 62:1038. (Pubitemid 26360372)